The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues

The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues

The interdisciplinary interim experts counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozins cardiovascular effects investigation and its clinical application in patients with type 2 d...

Full description

Bibliographic Details
Main Author: Editorial team Diabetes Mellitus
Format: Article
Language:English
Published: Endocrinology Research Centre 2016-05-01
Series:Сахарный диабет
Subjects:
empaglflozin
type 2 diabetes mellitus
cardiovascular disease
mortality
empa-reg outcome trial
Online Access:https://dia-endojournals.ru/dia/article/viewFile/7968/5748
Description
Summary:The interdisciplinary interim experts counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozins cardiovascular effects investigation and its clinical application in patients with type 2 diabetes at high cardiovascular risk.
ISSN:2072-0351
2072-0378

Similar Items